Accipiter Biosciences Inc. — Form D/A

Accipiter Biosciences Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2025-09-24. The offering totals $13.7M, of which $13.6M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Jose Antonio Mesa CejudoDirectorSeattle, WA
Matthew BickDirectorSeattle, WA
Javier CastellanosDirectorSeattle, WA
Heather GorhamDirectorSeattle, WA
Jiaping GuDirectorSeattle, WA
Matthew BickExecutive OfficerSeattle, WA
Javier CastellanosExecutive OfficerSeattle, WA
Hector De Jesus Rincon AranoExecutive OfficerSeattle, WA
Matthew BickPromoterSeattle, WA
Javier CastellanosPromoterSeattle, WA
Hector De Jesus Rincon AranoPromoterSeattle, WA
Heather RedmanRelated PersonSeattle, WA
Jose Antonio Mesa CejudoRelated PersonSeattle, WA
Matthew BickRelated PersonSeattle, WA
Javier CastellanosRelated PersonSeattle, WA
Hector De Jesus Rincon AranoRelated PersonSeattle, WA
William CanestaroRelated PersonSeattle, WA
William ArthurDirectorBainbridge, WA
William ArthurExecutive OfficerBainbridge, WA
William ArthurPromoterBainbridge, WA
Hector AranoDirectorBainbridge, WA
Hector AranoExecutive OfficerBainbridge, WA
Hector AranoPromoterBainbridge, WA
Randall SchatzmanRelated PersonSeattle, WA

Other filings by this issuer (3)

FiledFormOfferingSold
2026-07-28D$10.5M$10.5M
2024-05-28D$13.7M$7.9M
2023-05-02D$1.0M$650K

More